-
1 Comment
Wuhan Easy Diagnosis Biomedicine Co.,Ltd is currently in a long term uptrend where the price is trading 15.7% above its 200 day moving average.
From a valuation standpoint, the stock is 30.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.7.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd's total revenue rose by 637.9% to $280M since the same quarter in the previous year.
Its net income has increased by 3353.4% to $156M since the same quarter in the previous year.
Finally, its free cash flow grew by 279.5% to $30M since the same quarter in the previous year.
Based on the above factors, Wuhan Easy Diagnosis Biomedicine Co.,Ltd gets an overall score of 5/5.
| ISIN | CNE1000033Q7 |
|---|---|
| Sector | Healthcare |
| CurrencyCode | CNY |
| Exchange | SHE |
| Industry | Medical Devices |
| Market Cap | 4B |
|---|---|
| Target Price | None |
| PE Ratio | 110.82 |
| Dividend Yield | 0.8% |
| Beta | 0.83 |
Wuhan Easy Diagnosis Biomedicine Co.,Ltd. engages in the research and development, manufacture, and sale of in-vitro diagnostic products China and internationally. Its products portfolio includes molecular diagnostic products, such as PCR system, nucleic acid extraction and purification instrument, and sample release reagent; blood gas analyzer; immuno diagnosis, including chemiluminescence immunoassay, fluorescence immunity, and immunoquantitative analyzer; and automatic coagulation analyzer. The company also provides emergency and critical illness information solutions, including software, hardware, and certification consulting services; and third-party medical inspection services. It offers products in the areas of cardiovascular and cerebrovascular diseases, infectious diseases, kidney diseases, diabetes, infectious diseases, prenatal and postnatal care, health examination, thyroid, hormones, blood gas, coagulation, drug metabolism, pathogen detection, etc. Wuhan Easy Diagnosis Biomedicine Co.,Ltd. was founded in 2008 and is based in Wuhan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002932.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
